Overview

In this month's Journal Club, Dr Daniela Cardinale (European Institute of Oncology, Milan, IT), Dr Anne Blaes (Masonic Cancer Center, Minneapolis, US), Prof Dan Lenihan (Saint Francis Healthcare System, US) and Prof Joe Carver (University of Pennsylvania, US) discuss “Applying the ESC / IC-OS Guidelines: How do we actually do risk stratification?”.

The broadcast will explore risk stratification principles in Cardio-Oncology and the significance of serum biomarkers and imaging in predicting risk for patients with newly diagnosed breast cancer. Presentations will delve into recommended biomarkers and imaging techniques for accurate risk assessment. Additionally, the broadcast will discuss the challenging task of risk stratifying patients who have undergone cancer treatment more than five years ago. The objectives of the broadcast include outlining the fundamental principles of cardiovascular risk stratification, emphasising the role of serum biomarkers and imaging in risk prediction, and addressing appropriate surveillance and follow-up measures for cancer survivors.

The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits. 

This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.

The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS is collectively improving the overall outcomes including survival and quality of life. IC-OS aims to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.

Support Statement

This is an independent activity run by the International cardio-oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. IC-OS has been provided support to deliver this webinar series by Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.